Lost in Translation: CRF1 Receptor Antagonists and Addiction Treatment (original) (raw)

• Bale TL, Vale WW (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525–557.
  Article CAS PubMed Google Scholar
• Cole BJ, Cador M, Stinus L, Rivier J, Vale W, Koob GF (1990). Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res 512: 343–346.
  Article CAS PubMed Google Scholar
• Fleck BA, Hoare SR, Pick RR, Bradbury MJ, Grigoriadis DE (2012). Binding kinetics redefine the antagonist pharmacology of the corticotropin-releasing factor type 1 receptor. J Pharmacol Exp Ther 341: 518–531.
  Article CAS PubMed Google Scholar
• Grillon C, Hale E, Lieberman L, Davis A, Pine DS, Ernst M (2015). The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle. Neuropsychopharmacology 40: 1064–1071.
  Article CAS PubMed Central PubMed Google Scholar
• Heilig M, Epstein DE, Nader M, Shaham Y (2016). It is time to connect: addiction neuroscience and social context. Nat Rev Neurosci.
• Holsboer F, Ising M (2008). Central CRH system in depression and anxiety—evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583: 350–357.
  Article CAS PubMed Google Scholar
• Koob GF (2010). The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314: 3–14.
  Article CAS PubMed Google Scholar
• Koob GF, Bloom FE (1985). Corticotropin-releasing factor and behavior. Fed Proc 44 (1 Pt 2): 259–263.
  CAS PubMed Google Scholar
• Kwako LE, Spagnolo PA, Schwandt ML, Thorsell A, George DT, Momenan R et al (2015). The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study. Neuropsychopharmacology 40: 1053–1063.
  Article CAS PubMed Google Scholar
• Mantsch JR, Baker DA, Funk D, Le AD, Shaham Y (2016). Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology 41: 335–356.
  Article CAS PubMed Google Scholar
• Meyer RE, Mirin SM (1979) The Heroin Stimulus: Implications for a Theory of Addiction. Plenum Medical Book Company: New York.
  Book Google Scholar
• Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M et al (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A 93: 10477–10482.
  Article CAS PubMed Central PubMed Google Scholar
• Schwandt ML, Cortes CR, Kwako LE, George DT, Momenan R, Sinha R et al (2016). The CRF1 antagonist verucerfont in anxious alcohol dependent women: Translation of neuroendocrine, but not of anti-craving effects. Neuropsychopharmacology.
• Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J (1997). Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17: 2605–2614.
  Article CAS PubMed PubMed Central Google Scholar
• Sinha R, Shaham Y, Heilig M (2011). Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology (Berl) 218: 69–82.
  Article CAS Google Scholar
• Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36: 165–186.
  Article CAS PubMed Google Scholar
• Vale W, Spiess J, Rivier C, Rivier J (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394–1397.
  Article CAS PubMed Google Scholar
• Wikler A (1952). A psychodynamic study of a patient during experimental self-regulated re-addiction to morphine. Psychiatr Q 26: 270–293.
  Article CAS PubMed Google Scholar
• Wray JM, Gass JC, Tiffany ST (2013). A systematic review of the relationships between craving and smoking cessation. Nicotine Tob Res 15: 1167–1182.
  Article PubMed Central PubMed Google Scholar
• Zorrilla EP, Heilig M, de Wit H, Shaham Y (2013). Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend 128: 175–186.
  Article CAS PubMed Central PubMed Google Scholar